Structural Formula (Acy0a 0000 01)
Acyclovir Injection, Solution
Product Images NDC 65219-622
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 65219-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Acy0a 0000 02)
Package Label (PRINCIPAL DISPLAY)
Package Label (PRINCIPAL DISPLAY)
This text appears to be a description related to the printing of 2D barcodes, batch details, and information about Acyclovir Injection, USP. It includes details about the dosage, dilution instructions, composition, and packaging of the medication. The text also mentions the pH range and usage instructions for IV infusion. Additionally, it provides information about the manufacturer, Fresenius Kabi, and references their website.*
Package Label (PRINCIPAL DISPLAY)
Package Label (PRINCIPAL DISPLAY)
This is a product description for Acyclovir Injection, USP. It comes in 1,000 mg per 20 mL vials (50 mg per mL) intended for IV infusion. Prior to use, it must be diluted. The solution is sterile and nonpyrogenic. Each mL contains acyclovir sodium equivalent to 50 mg acyclovir, with a pH range of 10.85 to 11.50. The recommended dosage and storage conditions are also provided. The container closure is not made with natural rubber latex. This prescription medication is for intravenous use and should be handled as per the given instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
